Clinical Trials Transparency: write to your MEPs

All Trials Registered, All Results Reported

Write to your MEPs - All Trials Registered, All Results Reported, the #AllTrials Campaign
Find Email addresses and sample letters to write to MEPs about #AllTrials : do it today…

A committee of MEPs will soon vote on proposals that could increase transparency of clinical trials. However, there are 350 lobbyists for the pharmaceutical industry at the European Parliament and MEPs are now hearing their arguments against transparency every day. We have until 29th May to make sure they hear our arguments.

The Environment, Public Health and Food Safety Committee of the European Parliament, which is made up of 67 MEPs from 22 countries, is currently scrutinising the Clinical Trials Regulation. On Wednesday 29th May they will vote on changes to the regulation. There are proposals on the table that could greatly increase clinical trial transparency and would mean that all clinical trials for medicines licensed in Europe would have to be registered and the results reported.

Click here for Email addresses and sample letters to write to MEPs

Ex Pharmaceutical Industry Sales Rep Confessions

Rx Companies & the FDA – Gwen Olsen – the Rx Reformer

Gwen Olsen spent fifteen years as a very successful sales rep in the pharmaceutical industry working for health care giants including Johnson & Johnson, Syntex Labs, Bristol-Myers Squibb, Abbott Laboratories and Forest Laboratories. Now her new work is dedicated to the memory of her niece and her mission is to stop the over-medication of our children. Gwen is the author of Confessions of an Rx Drug Pusher and travels around the United States speaking to groups. In this video: Rx Companies & the FDA, Gwen sheds light on the relationship between the FDA and the major pharmaceutical companies.

  • Video by Gwen Olsen, Published on 25 Jan 2011

Related posts

Find out more

No Matter when it happens, Loss of a Pregnancy can be devastating

We need to change the way miscarriage and pregnancy loss is handled outside of the medical community

No Matter when it happens, Loss of a Pregnancy can be devastating
Personal Stories

It is an event in my life that I will never forget. I woke up one morning and after four weeks of nausea, fatigue and strange cravings, I felt “normal,” which seemed wrong. Everyone reassured me there was no reason to worry. I’d seen a strong heartbeat at a six-week ultrasound, I’d had no cramping or bleeding, and it is normal for pregnancy symptoms to fluctuate. But I just knew in my gut something was wrong.”

Continue reading No Matter When it Happens,
Loss of a Pregnancy Can Be Devastating
by Erica Berman, PhD, HuffPost Healthy Living, July 2012

Sadly for many DES daughters having their own children is not possible! Many of us who have experienced miscarriages, want to have kids but are struggling or unable to…

With no Advantage to Robotic Hysterectomies, why are Gynecologists pushing them?

Should you choose to have a robotic hysterectomy?

Should you choose to have a robotic hysterectomy?
Robotically assisted hysterectomy has increased dramatically

A hysterectomy (removing the uterus) can be done via one of the four methods: vaginal, laparoscopic surgery, robotic surgery and abdominal hysterectomy.
The American Congress of Obstetricians and Gynecologists recommends vaginal hysterectomy as the least invasive method with the best outcomes.
Why are gynecologists pushing robotic hysterectomies?

Read Should you choose to have a robotic hysterectomy?
by Jennifer Gunter, MD, 20 May 2013

Related posts:

What I thought I knew, Video with Alice Eve Cohen

Video by PenguinGroupUSA, Published on June 2009

Solo theater artist Alice Eve Cohen knew that childbearing was simply impossible – her own mother had taken DES, and Alice had a deformed uterus, among other disqualifiers. So when what doctors misdiagnosed as a tumor turned out to be a 6-month fetus, the 44-year-old Alice had to wrestle with clueless specialists, cavalier insurance companies, and her own no-see-um maternal instincts. A personal and medical odyssey beyond anything most women would believe possible.

Related posts

Find out more

Alterations in Estrogen Levels during Development affects the Skeleton: use of an Animal Model

Diethylstilbestrol DES side-effects on bones

Alterations in estrogen levels during development affects the skeleton: use of an animal model
DES side-effects on bones

Exposure to estrogens during various stages of development has been shown to irreversibly influence responsive target organs. The recent finding of the presence of estrogen receptor in both osteoblasts and osteoclasts has suggested a direct role of steroid hormones on bone tissue. Furthermore, estrogens have important effects on bone turnover in both humans and experimental animal models. Thus, this tissue is now regarded as a specific estrogen target tissue. To investigate whether a short-term developmental exposure to estrogens can influence bone tissue, we have injected female mice with diethylstilbestrol (DES) from day 1 through day 5 of life. Additionally, a group of pregnant female mice were injected with different doses of DES from day 9 through 16 of pregnancy. Mice were then weaned at 21 days of age, and effects on bone tissue of the female mice were evaluated in adulthood (7-12 months of age). These short-term treatments did not affect body weight of exposed mice. However, a dose-dependent increase in bone mass, both in the trabecular and compact compartments, was observed in the DES-exposed female offspring. Furthermore, femurs from DES-exposed females were shorter than femurs from controls. A normal skeletal mineralization accompanied these changes in the bone tissue. In fact, a parallel increase in total calcium content of the skeleton was found in concomitance with the increase in bone mass. Estrogen treatment induced an increase in the amount of mineralized skeleton when compared to untreated controls. In summary, this report shows that alterations of estrogen levels during development can influence the early phases of bone tissue development inducing permanent changes in the skeleton. These changes appear to be related to bone cell programming in early phases of life. ”

Abstract, NCBI Endocrinology, October 1995  – Full text here

Related post: Alterations of maternal Estrogen Levels during Gestation affect the Skeleton of Female Offspring, May 1996.

More DES DiEthylStilbestrol Resources

Ex Pharmaceutical Industry Sales Rep Confessions

Gwen Olsen the Rx Reformer on a Mission

This is the story of Gwen Olsen. She spent fifteen years as a very successful sales rep in the pharmaceutical industry working for health care giants including Johnson & Johnson, Syntex Labs, Bristol-Myers Squibb, Abbott Laboratories and Forest Laboratories. Now her new work is dedicated to the memory of her niece and her mission is to stop the over-medication of our children. Gwen is the author of Confessions of an Rx Drug Pusher and travels around the United States speaking to groups.

  • Video by Gwen Olsen, Published on 26 Jan 2011

Related posts

Find out more

Lots of Women believe Fertility Treatments give them the Opportunity to have Children when ready

Even family doctors believe reproductive technology is more effective than it is, expert says

Even family doctors believe reproductive technology is more effective than it is, expert says
Lots of Women believe Fertility Treatments can give them the Opportunity to have Children when ready…

Judith Daniluk, a professor in clinical psychology at the University of British Columbia conducted a study that questioned 3,300 childless women across Canada last year. The results showed that 91 per cent of women believed that IVF could help most women have a baby using their own eggs up until menopause…

Read Even family doctors believe reproductive technology is more effective than it is, expert says, by Erin Ellis, May 2013

Sadly for many DES daughters having their own children is not possible! Many of us who have experienced miscarriages, want to have kids but are struggling or unable to…

The Consequences of Mass PreNatal Progestin Exposure, 1950s-70s

Worse than thalidomide?

The consequences of mass prenatal progestin exposure, 1950s-70s
Worse than Thalidomide?

When we think of prenatal drug disasters, we usually think of the sedative thalidomide, which caused horrific birth defects, and synthetic estrogen DES, which caused cancer and infertility in offspring, among other horrors.

Ignored, however, have been the downstream effects of the extensive use of progestin drugs in obstetric and fertility practice from the late 1950s through today. Progestins, not estrogens, were the most widely used anti-miscarriage drugs during several decades of practice that placed near-unquestioning faith in modern pharmaceuticals combined with near-nonexistent concern about impacts on the fetus. ”

Read Worse than thalidomide?
by Jill Escher, Autism Exposed

DES DiEthylStilbestrol Resources

Signez la Pétition: Fin à la Loi du Silence Dégâts Distilbène et Indemnisation des Victimes DES

Signez la Pétition: Fin à la Loi du Silence Dégâts #Distilbène et Indemnisation des Victimes #DES
CLIQUER ICI POUR SIGNER LA PETITION

Un ENORME bravo à Anne-Laure Maingard du groupe victimes du Distilbène pour son initiative

Au ministère de la santé: Indemnisation des victimes du Distilbène

Pour que cesse la loi du silence sur les dégâts du distilbène imposée par les ministères de la santé et les laboratoires pharmaceutiques de 1945 à 1977

CLIQUER ICI POUR SIGNER LA PETITION

Le Distilbène DES, en savoir plus